These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Schnitzler syndrome, an autoimmune-autoinflammatory syndrome: report of two new cases and review of the literature. Tinazzi E; Puccetti A; Patuzzo G; Sorleto M; Barbieri A; Lunardi C Autoimmun Rev; 2011 May; 10(7):404-9. PubMed ID: 21256251 [TBL] [Abstract][Full Text] [Related]
9. Epidermolysis bullosa acquisita following bullous pemphigoid, successfully treated with the anti-CD20 monoclonal antibody rituximab. Wallet-Faber N; Franck N; Batteux F; Mateus C; Gilbert D; Carlotti A; Avril MF; Dupin N Dermatology; 2007; 215(3):252-5. PubMed ID: 17823525 [TBL] [Abstract][Full Text] [Related]
10. Anti-CD20 monoclonal antibody in acute life threatening haemolytic anaemia complicating childhood onset SLE. Abdwani R; Mani R Lupus; 2009 Apr; 18(5):460-4. PubMed ID: 19318402 [TBL] [Abstract][Full Text] [Related]
11. Anti-CD20 antibody in thrombotic thrombocytopenic purpura refractory to plasma exchange. Chow KV; Carroll R; Branley P; Nicholls K; Becker G; Hogan C Intern Med J; 2007 May; 37(5):329-32. PubMed ID: 17504282 [TBL] [Abstract][Full Text] [Related]
12. Successful therapy with rituximab of refractory acute humoral renal transplant rejection: a case report. Celik A; Saglam F; Cavdar C; Sifil A; Atila K; Sarioglu S; Bora S; Gulay H; Camsari T Transplant Proc; 2008; 40(1):302-4. PubMed ID: 18261611 [TBL] [Abstract][Full Text] [Related]
13. Rituximab (anti-CD20 monoclonal antibody)--ultimate or first choice in pemphigus? Hertl M; Eming R; Borradori L Dermatology; 2007; 214(4):275-7. PubMed ID: 17460396 [No Abstract] [Full Text] [Related]
14. Successful treatment of refractory skin manifestations of systemic lupus erythematosus with rituximab: report of a case. Uthman I; Taher A; Abbas O; Menassa J; Ghosn S Dermatology; 2008; 216(3):257-9. PubMed ID: 18182821 [No Abstract] [Full Text] [Related]
15. Rituximab as a treatment option for refractory endogenous anterior uveitis. Tappeiner C; Heinz C; Specker C; Heiligenhaus A Ophthalmic Res; 2007; 39(3):184-6. PubMed ID: 17534119 [TBL] [Abstract][Full Text] [Related]
16. Rituximab for myasthenia gravis: three case reports and review of the literature. Stieglbauer K; Topakian R; Schäffer V; Aichner FT J Neurol Sci; 2009 May; 280(1-2):120-2. PubMed ID: 19272616 [TBL] [Abstract][Full Text] [Related]
17. Treatment of refractory pemphigus with the anti-CD20 monoclonal antibody (rituximab). Marzano AV; Fanoni D; Venegoni L; Berti E; Caputo R Dermatology; 2007; 214(4):310-8. PubMed ID: 17460402 [TBL] [Abstract][Full Text] [Related]
18. Improvement of recurrent urticaria in a patient with Schnitzler syndrome associated with B-cell lymphoma with combination rituximab and radiotherapy. Murota H; Shoda Y; Ishibashi T; Sugahara H; Matsumura I; Katayama I J Am Acad Dermatol; 2009 Dec; 61(6):1070-5. PubMed ID: 19632739 [TBL] [Abstract][Full Text] [Related]
19. Successful treatment of mucous membrane pemphigoid with the anti-CD-20 antibody rituximab. Schumann T; Schmidt E; Booken N; Goerdt S; Goebeler M Acta Derm Venereol; 2009; 89(1):101-2. PubMed ID: 19197558 [No Abstract] [Full Text] [Related]
20. Sjögren keratoconjunctivitis sicca treated with rituximab. Zapata LF; Agudelo LM; Paulo JD; Pineda R Cornea; 2007 Aug; 26(7):886-7. PubMed ID: 17667631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]